Cognitive Disengagement Syndrome: History, Assessment, and Diagnostic Implications

A watercolor illustration of a young woman leaning her head on her hand at a desk, looking thoughtfully into the distance. In front of her sit a mug and a journal. Surrounding her head are ethereal, dreamy elements—a full moon, snowy mountain peaks, flying birds, spiral swirls, and a note reading, "So much on my mind, so little clarity ♡".

Cognitive disengagement syndrome (CDS) is an increasingly well-supported syndrome characterized by excessive daydreaming, mental fogginess or confusion, staring, slowed thinking or behavior, hypoactivity, fatigue, and daytime sleepiness. Although it was historically conceptualized as a possible subtype or feature of attention-deficit/hyperactivity disorder (ADHD), the contemporary literature supports CDS as related to, but empirically distinct from, ADHD inattention and other forms of psychopathology (Becker et al., 2023; Becker, 2025).

CDS is not currently a formal diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). However, the evidence base has advanced considerably, including clearer symptom measurement, replicated distinctions from ADHD inattention, and evidence of independent functional impairment. The central clinical question is no longer whether these symptoms are real or consequential. Rather, it is how CDS should ultimately be classified: as a distinct disorder, an ADHD specifier, or a transdiagnostic dimension that can occur across diagnostic categories (Becker, 2025).

From “Sluggish Tempo” to CDS

The history of CDS is closely intertwined with the history of ADHD. In the DSM-III era, attention deficit disorder was divided into two subtypes: ADD with hyperactivity and ADD without hyperactivity. Researchers studying children with attention difficulties but without overt hyperactivity began identifying a somewhat different profile. These children were more likely to appear drowsy, slow-moving, forgetful, withdrawn, confused, or “lost in a fog” than impulsive, disruptive, or behaviorally overactive peers.

In the 1980s, factor-analytic studies began to distinguish a “sluggish tempo” factor from an inattention-disorganization factor. The term sluggish cognitive tempo (SCT) eventually became the dominant label for this group of symptoms (Becker, 2025). Early research often assumed SCT might identify a more “pure” inattentive presentation of ADHD; a group whose attentional difficulties were not accompanied by hyperactivity or impulsivity.

That hypothesis was understandable, but it did not hold up cleanly. Although SCT/CDS and ADHD inattentive symptoms overlap substantially, they do not represent the same construct. Across studies, CDS symptoms cluster separately from ADHD inattention, and they demonstrate a different pattern of associated concerns. ADHD inattention is more consistently linked with externalizing problems, disorganization, and traditional executive-function difficulties. CDS, by contrast, is more strongly and consistently associated with internalizing symptoms, social withdrawal, low energy, sleep problems, mind wandering, and a subjective sense of cognitive disconnection from the external environment (Becker et al., 2023; Becker, 2025).

The terminology itself also required reconsideration. “Sluggish cognitive tempo” was criticized because it implied a known cognitive-processing deficit that had not been established and because many people experienced the phrase as pejorative or stigmatizing. In 2021, an international work group of 13 researchers convened to evaluate the evidence and reconsider the label. Following 10 meetings, review of the literature, and discussion with families, the group adopted cognitive disengagement syndrome as the preferred term (Becker et al., 2023).

The new name is not merely cosmetic. It reflects the current theory that the core issue may involve disengagement or decoupling of attention and conscious mental processing from the immediate external context. In other words, the person may not simply be inattentive in the conventional ADHD sense. They may become absorbed in internal thought, experience mental blankness or fogginess, have difficulty re-engaging with the present environment, and appear slowed or underactive as a result (Becker, 2025).

What CDS Is—and Is Not

CDS describes a persistent, developmentally inappropriate pattern of symptoms across three broad domains:

• Daydreaming and disengagement: zoning out, staring blankly, becoming lost in thought, appearing “in a fog,” and drifting away from the immediate environment.

• Mental confusion: losing one’s train of thought, difficulty translating thoughts into words, forgetting what one intended to say, feeling mentally mixed up, and experiencing slow or unclear thinking.

• Hypoactivity and lethargy: seeming underactive, moving slowly, fatigue, daytime sleepiness, and a low level of behavioral activation (Becker et al., 2023).

CDS is not synonymous with ADHD inattentive presentation. A client may have ADHD, CDS, both, or neither. The constructs are moderately to strongly associated, particularly CDS and ADHD inattention, but their overlap should not erase their differences. Meta-analytic evidence indicates stronger associations between CDS and ADHD inattention than between CDS and hyperactivity-impulsivity, yet the constructs remain separable in both child and adult samples (Becker et al., 2023).

CDS is also not interchangeable with depression, anxiety, trauma responses, sleep deprivation, autism-related cognitive differences, medical conditions, or medication effects. These conditions can contribute to or resemble aspects of CDS, and they frequently co-occur with elevated CDS symptoms. That is precisely why careful assessment matters. A person who appears slow, fatigued, disengaged, or cognitively foggy should not be assigned a CDS label without also considering sleep disorders, depression, anxiety, trauma-related dissociation, substance use, neurological conditions, medication effects, and other relevant contributors.

The literature does support, however, that CDS can be distinguished psychometrically from depression, anxiety, somatic complaints, ADHD hyperactivity-impulsivity, oppositional behavior, and sleep-related difficulties (Becker, 2025). These symptoms do not have to occur on their own to warrant clinical attention. They may provide important information that is overlooked when they are automatically attributed to another diagnosis.

Why Assessment Matters

Assessing CDS matters because many individuals have lived for years with difficulties that are clinically visible but poorly named. They may be described as unmotivated, lazy, passive, disengaged, slow, spacey, or not trying. These descriptions are often moralized rather than clinically examined. For clients, particularly those with high intelligence, advanced education, or histories of masking and compensation, the external appearance of functioning can obscure the effort required to remain cognitively connected and behaviorally engaged.

A thoughtful CDS assessment may clarify several important clinical questions.

First, it can help distinguish a pattern of cognitive disengagement from ADHD inattention. ADHD-related inattention may involve distractibility, poor sustained attention, disorganization, avoidance of effortful tasks, and difficulty following through. CDS may involve a different experiential profile: drifting inward, mental blankness, slowed thought, fatigue, staring, and difficulty becoming mentally activated. These patterns can co-occur, but they are not identical.

Second, CDS assessment can identify functional impairment that may otherwise be minimized. Elevated CDS symptoms have been associated with social withdrawal, lower social engagement, academic difficulties, poorer organizational and homework functioning, work-related impairment, perceived stress, lower quality of life, and internalizing concerns (Becker, 2025). In adults, the clinical impact may be especially apparent in work settings that require sustained cognitive engagement, rapid communication, frequent task-switching, self-directed time management, and real-time responsiveness.

Third, assessing CDS can improve differential diagnosis. A clinician should not assume that a client’s apparent cognitive slowing represents ADHD, depression, trauma, poor motivation, or a characterological issue. Similarly, a high score on a CDS measure should not be treated as proof of a separate syndrome. Instead, CDS symptoms should prompt a more careful evaluation of sleep, mood, anxiety, trauma, substance use, medical issues, autism, learning disorders, and medication-related effects.

Finally, assessment is important because it may guide accommodations and intervention planning even before DSM recognition occurs. A person who experiences frequent cognitive fog, mind wandering, fatigue, and slow task initiation may benefit from environmental supports that differ somewhat from the supports typically emphasized for impulsive or hyperactive ADHD. These may include reduced cognitive load, written follow-up after verbal instructions, opportunities for reorientation, predictable routines, paced work demands, breaks, external cueing, and interventions that address sleep and internalizing symptoms.

Where CDS Stands in the DSM

CDS is not included as a standalone diagnosis, formal specifier, or ADHD presentation in the DSM-5-TR. It is also important to be precise about what that means: CDS cannot currently be formally diagnosed under DSM criteria in the same manner as ADHD, major depressive disorder, generalized anxiety disorder, or autism spectrum disorder.

At the same time, DSM absence should not be mistaken for scientific absence. The international CDS work group concluded that the construct has reached the threshold for recognition as a distinct syndrome, based on evidence for its coherent symptom structure, distinction from ADHD and other psychopathology dimensions, and links with clinically meaningful outcomes (Becker et al., 2023). That conclusion is significant, but it is not equivalent to formal diagnostic inclusion.

The path to DSM inclusion requires more than evidence that a symptom cluster exists. Proposed changes must demonstrate validity, reliability, clinical utility, and careful consideration of potential harms or unintended consequences. The American Psychiatric Association’s current continuous-improvement process invites structured proposals and requires supporting evidence for any substantive diagnostic revision (American Psychiatric Association, 2026). At present, CDS research has not yet produced a universally accepted diagnostic threshold, normative framework, developmental course, or evidence-based intervention pathway sufficient to settle how it should be classified.

Several possibilities remain for how CDS might ultimately be classified. Recognizing it as a separate disorder would require its own diagnostic criteria, including symptom thresholds, duration requirements, evidence of impairment, and guidance for differential diagnosis. More research is needed on its prevalence, developmental course, etiology, treatment response, and boundaries with other conditions before this approach can be adequately evaluated.

Another possibility is to classify CDS as an ADHD specifier, identifying a clinically meaningful subgroup of people with ADHD. However, this approach would not fully account for individuals who experience CDS symptoms without ADHD. It would also need to reflect that CDS symptoms are not present in everyone with ADHD.

Alternatively, CDS could be understood as a transdiagnostic dimension assessed across multiple clinical presentations, including ADHD, internalizing conditions, autism, and sleep-related difficulties. This approach would allow clinicians to consider cognitive disengagement regardless of a person’s primary diagnosis, although questions about clinical implementation and meaningful symptom thresholds remain unresolved.

For now, CDS remains a research construct with an expanding evidence base and established assessment measures, but without formal DSM diagnostic status. Its eventual classification will depend on further evidence about which approach most accurately describes the syndrome and supports clinical assessment and care.

This uncertainty should not be interpreted as a weakness in the construct. Rather, it reflects appropriate scientific caution. The field has moved beyond asking whether CDS is simply “ADHD without hyperactivity.” It is now grappling with the more sophisticated question of how best to classify a valid syndrome that may cut across traditional diagnostic boundaries (Becker, 2025).

Available CDS Measures

The assessment literature has improved substantially since the early years, when researchers relied largely on a small number of items pulled from broad behavior checklists. A systematic review identified nine measures developed to assess SCT/CDS, including child, adolescent, adult, self-report, parent-report, teacher-report, and collateral-report tools. The review found acceptable to excellent reliability across measures and particularly strong support for the Child and Adolescent Behavior Inventory, the Child Concentration Inventory–Second Edition, and the Barkley Adult ADHD Rating Scale–IV for their respective populations and informant formats (Becker, 2021).

Child and adolescent measures

Child and Adolescent Behavior Inventory (CABI): The CABI includes parent- and teacher-report scales and has parallel self-report versions. It is one of the strongest available options for assessing CDS symptoms in children and adolescents because it incorporates the empirically supported symptom set and permits multi-informant evaluation. Parent and teacher data are especially valuable when symptoms vary by setting or when the child’s internal experience differs from observable behavior.

Child Concentration Inventory–Second Edition (CCI-2): The CCI-2 is a youth self-report measure designed to assess CDS symptoms. It is useful because children and adolescents may have direct insight into internal experiences such as mental fogginess, drifting into thought, losing their train of thought, or feeling disconnected during tasks. Self-report should still be interpreted alongside caregiver, teacher, and clinical data.

Barkley Child Attention Scale (BCAS): The BCAS provides another option for assessing CDS-related symptoms in children. In practice, clinicians should pay close attention to the exact items included, the informant source, the measure’s normative data, and whether the instrument adequately differentiates CDS symptoms from ADHD inattention and internalizing concerns.

Adult measures

Adult Concentration Inventory (ACI): The ACI is a self-report measure designed specifically to assess CDS in adults. It has been evaluated in adult samples and has shown promising psychometric support across multiple cultural contexts. The measure was developed to distinguish CDS symptoms from ADHD inattention and internalizing symptoms, although clinicians should interpret results cautiously and in the context of a comprehensive evaluation (Fredrick & Becker, 2021; Sadeghi-Bahmani et al., 2023).

Barkley Adult ADHD Rating Scale–IV (BAARS-IV) Sluggish Cognitive Tempo Scale: The BAARS-IV includes an SCT/CDS scale and has particularly strong support among adult self-report measures. It can be helpful in adult ADHD evaluations because it permits direct examination of both ADHD symptoms and CDS symptoms within the same broader assessment context (Becker, 2021).

Emerging approaches

A semi-structured clinical interview for the 15 empirically supported CDS symptoms has shown promising psychometric support, representing an important development beyond rating scales alone (Becker, 2025). This matters because rating scales are screening and measurement tools, not substitutes for clinical reasoning.

At present, there is no single gold-standard diagnostic instrument for CDS. There are also no formally established DSM diagnostic cutoffs. A responsible assessment approach therefore integrates symptom ratings with developmental history, cross-setting impairment, collateral information, diagnostic interviewing, medical and sleep screening, and assessment of co-occurring conditions.

A Clinically Responsible Assessment Process

A CDS-informed evaluation should be comprehensive rather than checklist-driven. The goal is not to force a new diagnosis onto a familiar presentation. The goal is to understand the person’s pattern of functioning accurately enough to avoid reducing everything to ADHD, depression, anxiety, or “motivation.”

A clinically sound process may include:

• A detailed clinical interview. Explore the onset, persistence, context, and functional consequences of daydreaming, cognitive fogginess, slowed thinking, fatigue, hypoactivity, disengagement, and difficulty re-entering tasks or conversations.

• Developmental history. Determine whether symptoms were present in childhood and whether they appeared across settings. Ask about school feedback, report cards, teacher comments, family observations, and developmental transitions.

• Multi-informant rating scales. When possible, obtain self-report and collateral information. Adult partners, parents, or close family members may offer important observations regarding day-to-day disengagement, pace, fatigue, and social functioning.

• ADHD assessment. Evaluate ADHD carefully rather than assuming that CDS symptoms are inattentive ADHD. This includes examining childhood onset, persistence, impairment, and the full ADHD symptom profile.

• Mood, anxiety, trauma, and suicidality screening. CDS is associated with internalizing symptoms and may be linked with elevated suicidal ideation or risk even after accounting for ADHD symptoms. This does not establish causality, but it makes thorough assessment ethically necessary (Becker, 2025).

• Sleep and medical assessment. Daytime sleepiness, chronic fatigue, sleep-disordered breathing, circadian disruption, medication effects, endocrine issues, neurological conditions, and other medical factors require consideration before attributing slowed or foggy functioning to CDS.

• Functional assessment. Identify the actual impact on school, work, social relationships, daily living, driving, self-care, communication, and quality of life. Symptoms become clinically meaningful not merely because they are present, but because they contribute to distress or impairment.

• Strengths and contextual analysis. A person may have advanced degrees, a successful career, or a high level of intelligence and still experience clinically significant CDS symptoms. Achievement does not negate impairment; it may instead reflect exceptional effort, compensation, environmental fit, external support, or a heavy personal cost.

Implications for Clinical Practice

The emergence of CDS challenges clinicians to think more carefully about what “inattention” looks like. Not all attention-related struggles are characterized by distractibility, impulsivity, disorganization, or hyperactivity. Some clients struggle because they repeatedly drift away from the external world, experience cognitive fog, feel chronically slowed or depleted, and have difficulty mobilizing their attention toward the demands in front of them.

This distinction matters clinically. When a client’s presentation is understood only through the lens of ADHD, depression, or poor motivation, important aspects of their experience may be missed. Conversely, when CDS is treated as an explanation for every instance of fatigue, disengagement, or slowed performance, clinicians risk overlooking treatable sleep, mood, trauma-related, medical, or environmental contributors.

The most ethically sound position is one of both recognition and restraint. CDS deserves assessment because the evidence increasingly supports it as a meaningful syndrome associated with real impairment. It does not yet warrant casual overdiagnosis or claims that it is already a settled DSM disorder. The task for clinicians is to use the available evidence to listen more precisely, assess more broadly, and formulate more accurately.

For many clients, being able to name the pattern is not a minor matter. It may be the first time their experience has been understood as more than laziness, lack of effort, or a personal failure. That recognition should not end the assessment process. It should begin a more careful one.

References

American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.).

American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.).

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).

American Psychiatric Association. (2026). Submit proposals for making changes to DSM-5-TR. https://www.psychiatry.org/psychiatrists/practice/dsm/submit-proposals

Becker, S. P. (2021). Systematic review: Assessment of sluggish cognitive tempo over the past decade. Journal of the American Academy of Child & Adolescent Psychiatry, 60(6), 690–709. https://doi.org/10.1016/j.jaac.2020.10.016

Becker, S. P. (2025). Cognitive disengagement syndrome: A construct at the crossroads. American Psychologist, 80(5), 812–834. https://doi.org/10.1037/amp0001517

Becker, S. P., Burns, G. L., Garner, A. A., Jarrett, M. A., Luebbe, A. M., Epstein, J. N., & Willcutt, E. G. (2018). Sluggish cognitive tempo in adults: Psychometric validation of a self-report measure. Journal of Clinical Psychology, 74(9), 1625–1648. https://doi.org/10.1002/jclp.22629

Becker, S. P., Leopold, D. R., Burns, G. L., Jarrett, M. A., Langberg, J. M., Marshall, S. A., McBurnett, K., & Willcutt, E. G. (2016). The internal, external, and diagnostic validity of sluggish cognitive tempo: A meta-analysis and critical review. Journal of the American Academy of Child & Adolescent Psychiatry, 55(3), 163–178. https://doi.org/10.1016/j.jaac.2015.12.006

Becker, S. P., Willcutt, E. G., Leopold, D. R., Fredrick, J. W., Smith, Z. R., Jacobson, L. A., Burns, G. L., Mayes, S. D., Waschbusch, D. A., Froehlich, T. E., McBurnett, K., Servera, M., & Barkley, R. A. (2023). Report of a work group on sluggish cognitive tempo: Key research directions and a consensus change in terminology to cognitive disengagement syndrome. Journal of the American Academy of Child & Adolescent Psychiatry, 62(6), 629–645. https://doi.org/10.1016/j.jaac.2022.07.821

Fredrick, J. W., & Becker, S. P. (2021). Examining the structural and external validity of the Adult Concentration Inventory for assessing sluggish cognitive tempo in adults. Assessment, 29(5), 1005–1021. https://doi.org/10.1177/10731911211027224

Sadeghi-Bahmani, D., Brand, S., Khazaie, H., et al. (2023). Validation of the Farsi version of the Adult Concentration Inventory for assessing cognitive disengagement syndrome in adults. BMC Psychology, 11, Article 212. https://doi.org/10.1186/s40359-023-01242-6